Stock Rich List
Nasdaq: MRNA

Moderna insiders

The officers, directors and 10% owners of Moderna, Inc. who hold the most stock, valued at the live MRNA price.

$199.33
MRNA today +$2.5M (+1.29%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
13
Their MRNA stock
$4.48B
Market value
$81.19B
Held by ranked insiders
5.51%

Insiders by value of MRNA holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Robert LangerDirector11,481,093$2.29B2.82%136th
2Stephane BancelChief Executive Officer6,440,260$1.28B1.58%211th
3Noubar B. AfeyanDirector2,227,939$444M0.55%520th
4Stephen HogePresident1,467,144$292M0.36%692nd
5Paul SaganDirector494,133$98.5M0.12%1522nd
6Juan AndresChief Operating Officer125,000$24.9M<0.1%4255th
7Shannon Thyme KlingerChief Legal Officer81,340$16.2M<0.1%6047th
8James M. MockChief Financial Officer60,125$12.0M<0.1%6059th
9Francois NaderDirector32,781$6.5M<0.1%11982nd
10Elizabeth G. NabelDirector19,317$3.9M<0.1%13050th
11Sandra HorningDirector18,585$3.7M<0.1%5116th
12David M. RubensteinDirector9,643$1.9M<0.1%269th
13Elizabeth E. TallettDirector4,761$949K<0.1%14480th

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Moderna; see each profile for the filing.